Results 71 to 80 of about 16,901 (224)
Lassa Virus Infection: a Summary for Clinicians
This summary on Lassa virus (LASV) infection and Lassa fever disease (LF) was developed from a clinical perspective to provide clinicians with a condensed, accessible understanding of the current literature. The information provided highlights pathogenesis, clinical features, and diagnostics emphasizing therapies and vaccines that have demonstrated ...
Vanessa Raabe +17 more
openaire +3 more sources
ZNRD2 Mediated Nucleoprotein Aggregation Impairs Respiratory Syncytial Virus Replication
During RSV infection, nucleoprotein (N) forms RNA‐bound oligomers. The host protein ZNRD2 binds to these oligomers, promoting their transition into insoluble aggregates. These aggregates simultaneously sequester functional N to restrict viral production and disrupt chaperonin assembly quality control by interfering with ZNRD2's role as an adaptor ...
Haiwu Zhou +8 more
wiley +1 more source
New Lineage of Lassa Virus, Togo, 2016
We describe a strain of Lassa virus representing a putative new lineage that was isolated from a cluster of human infections with an epidemiologic link to Togo. This finding extends the known range of Lassa virus to Togo.
Shannon L.M. Whitmer +40 more
doaj +1 more source
Ever since it was established that rodents serve as reservoirs of the zoonotic Lassa virus (LASV), scientists have sought to answer the questions: which populations of rodents carry the virus?
Ayodeji Olayemi, Elisabeth Fichet-Calvet
doaj +1 more source
Review of candidate vaccines for the prevention of Lassa fever
The Lassa virus one of the main etiological agent of hemorrhagic fevers in the world: according to WHO estimates, it affects 100,000 to 300,000 people annually, which results in up to 10,000 deaths [1].
O. D. Popova +9 more
doaj +1 more source
Cellular Factors Required for Lassa Virus Budding [PDF]
ABSTRACT It is known that Lassa virus Z protein is sufficient for the release of virus-like particles (VLPs) and that it has two L domains, PTAP and PPPY, in its C terminus. However, little is known about the cellular factor for Lassa virus budding. We examined which cellular factors are used in Lassa virus Z budding.
Shuzo, Urata +4 more
openaire +2 more sources
As West Africa urbanises, the risk of Lassa fever may paradoxically decrease. We found the invasive house mouse, a dominant urban species, outcompetes and displaces the primary Lassa virus host. Considering these species interactions is critical for accurately predicting future zoonotic disease patterns.
David Simons +13 more
wiley +1 more source
Detection of Antibody and Antigen for Lassa Virus Nucleoprotein in Monkeys from Southern Nigeria
Lassa fever is a deadly viral haemorrhagic fever caused by Lassa Virus (LASV). Rodents, especially, Mystomys natalensis, are the known reservoirs of LASV and humans are the defined hosts.
Bamidele Nyemike Ogunro +6 more
doaj +1 more source
High crossreactivity of human T cell responses between Lassa virus lineages.
Lassa virus infects hundreds of thousands of people each year across rural West Africa, resulting in a high number of cases of Lassa fever (LF), a febrile disease associated with high morbidity and significant mortality.
Brian M Sullivan +28 more
doaj +1 more source
Ebola virus disease epidemic in West Africa: Lessons learned and issues arising from West African countries [PDF]
© Royal College of Physicians 2015. All rights reserved.The current Ebola virus disease (EVD) outbreak ravaging three nations in West Africa has affected more than 14,000 persons and killed over 5,000.
Akpalu, AK +6 more
core +1 more source

